BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6099753)

  • 1. The antiemetic effect of methylprednisolone in patients treated with cis-platinum (CDDP) for advanced testicular germ cell tumors.
    Salvioni R; Faustini M; Piva L; Pasi M; Pizzocaro G
    Chemioterapia; 1984 Aug; 3(4):223-6. PubMed ID: 6099753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
    Niijima T; Isurugi K; Akaza H; Kondo Y; Kawabe K; Fujita K; Koiso K; Yokoyama M; Kinoshita K; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2376-82. PubMed ID: 3729492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group].
    Uchida K; Akaza H; Shimazui T; Kikuchi K; Manabe F; Iwasaki A; Ishikawa S; Noguchi R; Otani M; Hattori K; Kondo F; Nishijima Y; Sato K; Koiso K; Hinotsu S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):81-6. PubMed ID: 8546475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dosage methylprednisolone as an antiemetic in cytostatic-induced vomiting].
    Joss R; Gervasi A; Goldhirsch A; Brunner KW
    Schweiz Med Wochenschr; 1983 Mar; 113(12):426-9. PubMed ID: 6857194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corticosteroid as an anti-emetic agent in cancer chemotherapy with cis-diammine-dichloroplatinum (II)].
    Samma S; Yoshikawa M; Futami T; Hayashi Y; Horii Y; Kubota K; Babaya K; Hirao Y; Okajima E; Ohara S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):561-5. PubMed ID: 4039918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improved antiemetic treatment with levomepromazine (author's transl)].
    Higi M; Niederle N; Schmidt CG; Seeber S
    Dtsch Med Wochenschr; 1980 May; 105(22):794-5. PubMed ID: 7190888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticancer regimen combined with methylprednisolone--its antiemetic effect].
    Lee K; Uchida T; Koshiba K; Shoji K; Egawa S; Fukuda Y
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1466-72. PubMed ID: 6683484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
    J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetics for patients treated with antitumor chemotherapy.
    Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
    Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer].
    Kurita A; Takashima S; Nakata M; Kubo Y; Saiki T; Ohsumi S; Yokoyama N; Tanada M; Takiyama W; Saeki H
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):49-54. PubMed ID: 9020945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
    Hisano C; Nakano S; Okuma K; Masumoto N; Fujishima H; Nakamura M; Niho Y
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1175-81. PubMed ID: 8751806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental chemotherapy of human testicular carcinoma transplanted in nude mice].
    Yanagisawa M; Machida T; Miki M; Tanino M; Akasaka Y; Higashi Y; Kondo N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1299-307. PubMed ID: 6191680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
    Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective control of cisplatin-induced nausea using high-dose steroids and droperidol.
    Mason BA; Dambra J; Grossman B; Catalano RB
    Cancer Treat Rep; 1982 Feb; 66(2):243-5. PubMed ID: 7198937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.